Personal profile


Haemato-oncologist. Responsible for treatment of malignant lymphoma and for experimental/phase I treatment of haematological malignancies at Rigshospitalet. Head of service for Hodgkin lymphoma, Mantle cell lymphoma and Castleman’s disease.


Main research areas

Hodgkin lymphoma; Mantle cell lymphoma; PET/CT in lymphoma; PET-response adapted lymphoma treatment; Phase 1 haematology studies;


Current research

Chairman of the  EORTC lymphoma group since 2013. Co-author of the international response criteria and guidelines for the use of imaging in lymphoma. Co-author of the European society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.

Faculty member for the EHA Clinical Research Training in Haematology programme

Member of the scientific committee for the European Haematology Association

National principal investigator or sub-investigator for >25 solid tumour and haematology phase I trials

National principal investigator for three mantle cell lymphoma trials (one ongoing and two planned) and three Hodgkin lymphoma trials.

Site principal investigator or sub-investigator for >20 lymphoma and myeloma phase II and phase III trials


Potential conflicts of interest



Dive into the research topics where Martin Hutchings is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or